Compare ATRC & RVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | RVLV |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2005 | 2019 |
| Metric | ATRC | RVLV |
|---|---|---|
| Price | $41.46 | $28.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $52.00 | $26.00 |
| AVG Volume (30 Days) | 553.2K | ★ 945.5K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.78 |
| EPS | N/A | ★ 0.78 |
| Revenue | $518,304,999.00 | ★ $1,195,039,000.00 |
| Revenue This Year | $16.90 | $8.95 |
| Revenue Next Year | $12.29 | $6.42 |
| P/E Ratio | ★ N/A | $36.99 |
| Revenue Growth | ★ 15.80 | 9.24 |
| 52 Week Low | $28.29 | $16.80 |
| 52 Week High | $43.11 | $39.58 |
| Indicator | ATRC | RVLV |
|---|---|---|
| Relative Strength Index (RSI) | 68.77 | 73.40 |
| Support Level | $38.92 | $25.48 |
| Resistance Level | $41.12 | $29.32 |
| Average True Range (ATR) | 1.81 | 1.28 |
| MACD | 0.63 | 0.47 |
| Stochastic Oscillator | 89.97 | 91.23 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.